BC
BIO icon

Brinker Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Brinker Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$3.39M Buy
7,502
+252
+3% +$111K 0.11% 192
2020
Q1 		$2.54M Sell
7,250
-120
-2% -$44.1K 0.1% 201
2019
Q4 		$2.73M Buy
7,370
+29
+0.4% +$10.2K 0.08% 232
2019
Q3 		$2.44M Buy
7,341
+24
+0.3% +$7.83K 0.08% 234
2019
Q2 		$2.29M Sell
7,317
-71
-1% -$21.3K 0.08% 237
2019
Q1 		$2.26M Buy
7,388
+2,123
+40% +$573K 0.09% 238
2018
Q4 		$1.22M Sell
5,265
-266
-5% -$71.4K 0.05% 349
2018
Q3 		$1.73M Buy
5,531
+2,664
+93% +$827K 0.06% 335
2018
Q2 		$827K Sell
2,867
-814
-22% -$225K 0.03% 543
2018
Q1 		$921K Sell
3,681
-154
-4% -$39.2K 0.04% 485
2017
Q4 		$915K Sell
3,835
-206
-5% -$49.9K 0.04% 458
2017
Q3 		$898K Buy
+4,041
New +$909K 0.04% 447
2017
Q2 		– Sell
-4,129
Closed -$823K – 676
2017
Q1 		$823K Sell
4,129
-456
-10% -$87.8K 0.04% 426
2016
Q4 		$836K Buy
+4,585
New +$782K 0.05% 338

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brinker Capital's BIO Position: Q2 2020 in Review

Brinker Capital increased its Bio-Rad Laboratories Class A (BIO) stake by 3.5% in Q2 2020, buying an estimated $111K and bringing the position to 7,502 shares worth $3.39M. The position accounts for 0.11% of the portfolio, ranked #192.

Brinker Capital first reported a position in BIO in Q4 2016 and has held it in 14 quarters since. 470 funds tracked by Wall St. Rank hold BIO as of Q2 2020.

  • Brinker Capital held 7,502 shares of Bio-Rad Laboratories Class A worth $3.39M as of Q2 2020.
  • Brinker Capital bought 252 Bio-Rad Laboratories Class A shares in Q2 2020, an estimated $111K.
  • Bio-Rad Laboratories Class A made up 0.11% of Brinker Capital's portfolio in Q2 2020, its #192 holding.
  • Brinker Capital first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and has held it in 14 quarters since.
  • 470 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.